Basel Medical Group Ltd (BMGL)

NASDAQ: BMGL · Real-Time Price · USD

2.000

-0.040 (-1.96%)

At close: Sep 2, 2025, 4:00 PM

1.970

-0.030 (-1.50%)

After-hours: Sep 2, 2025, 6:00 PM EDT

Basel Medical Group Income Statement

Financials in millions SGD. Fiscal year is July - June.

Millions SGD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Dec '24 Dec 31, 2024	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Operating Revenue	10	10.05	9.7	10.66
Other Revenue	0.02	0.02	0.05	-
Revenue	10.02	10.07	9.75	10.66
Revenue Growth (YoY)	2.28%	3.32%	-8.55%	-
Cost of Revenue	7.19	5.89	5.58	2.72
Gross Profit	2.83	4.18	4.16	7.94
Selling, General & Admin	0.82	0.7	1.05	5.78
Other Operating Expenses	1.7	0.81	0.55	-0.31
Operating Expenses	3.14	2.04	2.16	5.48
Operating Income	-0.31	2.14	2	2.46
Interest Expense	-0.28	-0.18	-0.24	-0.32
Interest & Investment Income	-	-	0.3	0.25
Other Non Operating Income (Expenses)	0.74	0.44	0.07	-
Pretax Income	0.15	2.4	2.13	2.39
Income Tax Expense	-0.28	0.33	0.35	0.41
Net Income	0.43	2.07	1.78	1.98
Net Income to Common	0.43	2.07	1.78	1.98
Net Income Growth	-82.88%	16.23%	-9.84%	-
Shares Outstanding (Basic)	16	16	16	16
Shares Outstanding (Diluted)	16	16	16	16
EPS (Basic)	0.03	0.13	0.11	0.12
EPS (Diluted)	0.03	0.13	0.11	0.12
EPS Growth	-82.88%	16.23%	-9.84%	-
Free Cash Flow	-1.44	2.5	2.59	2.7
Free Cash Flow Per Share	-0.09	0.15	0.16	0.17
Gross Margin	28.24%	41.54%	42.71%	74.48%
Operating Margin	-3.05%	21.24%	20.55%	23.09%
Profit Margin	4.28%	20.58%	18.30%	18.56%
Free Cash Flow Margin	-14.40%	24.84%	26.61%	25.37%
EBITDA	-0.27	2.17	2.03	2.48
EBITDA Margin	-2.70%	21.54%	20.86%	23.30%
D&A For EBITDA	0.03	0.03	0.03	0.02
EBIT	-0.31	2.14	2	2.46
EBIT Margin	-3.05%	21.24%	20.55%	23.09%
Effective Tax Rate	-	13.80%	16.34%	17.12%

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q